POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 43 | / | 2013 | ||||||||
Date of issue: | 2013-04-04 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
Sopharma monthly March 2013 | |||||||||||
Official market - legal basis | |||||||||||
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
The Board of Directors of Sopharma AD (the “Company") notifies that for March 2013 Sopharma AD realized a decrease of sales revenues of 10% compared to the same period of 2012, including 12% increase of domestic sales and 20% decrease of export sales. During the past three months Sopharma AD recorded a decrease of sales revenues of 4%, including 5% increase of domestic sales and 8% decrease of export sales compared to 2012. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
Sopharma monthly March 2013.doc | Sopharma monthly March 2013 |
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2013-04-04 | Ognian Donev | Executive Director |